ReviewHuman vaccines & immunotherapeutics2021

PD-1/PD-L1 immune checkpoint inhibitors in glioblastoma: clinical studies, challenges and potential.

Tianrui Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.